Shares in Bruker BioSciences gained 11.4 percent over the past three weeks, leading the 11 firms whose shares rose during the three-week trading period ended Tuesday (Note: BioCommerce Week did not publish the past two weeks). Bio-Rad posted the next-largest increase with a gain of 6.8 percent.
 
Stratagene slumped again to a new 52-week low to close at $4.70 on Tuesday, down 14.4 percent for the three-week period.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.